Skip to main content
Clinical Trials/NCT00833196
NCT00833196
Completed
Not Applicable

An International, Observational Study to Define Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia

Ipsen36 sites in 9 countries404 target enrollmentFebruary 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Idiopathic Cervical Dystonia
Sponsor
Ipsen
Enrollment
404
Locations
36
Primary Endpoint
Responder rate at peak effect following one BoNT-A injection cycle without any deviations from routine practice
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A post marketing, international, multicenter, observational, prospective, longitudinal study. The purpose of the study is to describe cervical dystonia sub-types with their injection protocols and response to BoNT-A.

Registry
clinicaltrials.gov
Start Date
February 2009
End Date
April 2010
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ipsen
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Idiopathic cervical dystonia
  • TWSTRS severity score ≥ 15
  • At least a 12-week interval between the last injection (BoNT-A or BoNTB) and inclusion
  • Written informed consent prior to collect the data

Exclusion Criteria

  • Contraindications to any BoNT-A preparations
  • Secondary cervical dystonia
  • Subject already been included in the study

Outcomes

Primary Outcomes

Responder rate at peak effect following one BoNT-A injection cycle without any deviations from routine practice

Time Frame: Around 4 weeks post injection

Secondary Outcomes

  • To describe subject and investigator's CGI scores(Around 4 weeks post injection)
  • To describe TWSTRS change scores from inclusion (total score & subscales scores)(Baseline, and around 4 weeks and 3 months post injection)
  • To describe tremor change score from inclusion (TSUI scale)(Baseline, and around 4 weeks and 3 months post injection)
  • To describe the Cervical Dystonia Impact Profile (CDIP) 58 change from inclusion(Baseline, and around 4 weeks post injection)
  • To identify prognostic factors for response (Exploratory Objective)(baseline, and around 4 weeks and 3 months post injection)

Study Sites (36)

Loading locations...

Similar Trials